Announcements Trials
Browse Landscape

Status

Completed 6Recruiting 2Active not recruiting 2Withdrawn 1Unknown 1Approved for marketing 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 1

Interventions

Imatinib Mesylate 6Laparoscopy 3Surgical Procedures, Operative 2spartalizumab 1ripretinib 1regorafenib 1ponatinib 1famitinib 1apixaban 1anlotinib 1Thoracic Surgery, Video-Assisted 1TH 302 1Surveys and Questionnaires 1Surgical Tape 1Sunitinib 1Rivaroxaban 1Oxaliplatin 1Nivolumab 1Liver Transplantation 1Ipilimumab 1Interviews as Topic 1Endoscopic Mucosal Resection 1Dasatinib 1Dalteparin 1Blood Specimen Collection 1Biopsy 168Ga-NOTA-RM26 15-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Gastrointestinal Stromal Tumors × ripretinib × Clear all
NCT05697107 2023-01-25

Ripretinib in Chinese Patients With Advanced GIST: a Real World Study

Peking University

Unknown
308 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡